Related Experiment Video
Updated: Jun 23, 2026
15:42
Xenotransplantation of Human Stem Cells into the Chicken Embryo
Published on: July 11, 2010
Clinically failed eggs as a source of normal human embryo stem cells.
Paul A De Sousa1, John Gardner, Sharon Sneddon
1MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4SB, UK. paul.desousa@ed.ac.uk
Stem Cell Research
|April 28, 2009
Summary
This study developed a new method to create human embryo stem cells (hESCs) from failed eggs, avoiding ethical concerns. The resulting RCM1 cell line is a normal, euploid hESC, offering a promising alternative for regenerative medicine.
Area of Science:
- Stem Cell Biology
- Reproductive Medicine
- Bioethics
Background:
- Human embryo stem cells (hESCs) hold great potential for regenerative medicine.
- Ethical and practical challenges exist in sourcing eggs and embryos for hESC derivation.
- Alternative methods are needed to minimize conflicts with donor reproductive interests.
Purpose of the Study:
- To isolate a human embryo stem cell (hESC) line from clinically failed eggs.
- To ensure the derived hESC line does not conflict with donor interests in conception.
- To demonstrate an alternative strategy for generating normal hESC lines.
Main Methods:
- Utilized 579 clinically failed or abnormally fertilized eggs (3PN or no PN).
- Applied recovery interventions including ICSI or parthenogenetic stimulation.
- Derived and characterized one hESC line (RCM1) from a recovered, failed-to-fertilize egg.
Main Results:
- Successfully derived one hESC line (RCM1) via parthenogenetic activation of a recovered egg.
- RCM1 exhibited standard in vitro and in vivo characteristics of a normal euploid hESC line.
- Whole-genome SNP analysis confirmed RCM1 as biparental, indicating sperm penetration and parthenogenetic activation.
Conclusions:
- Clinically failed eggs can be a viable source for generating normal hESC lines.
- This method minimizes potential conflicts with donor reproductive interests.
- The RCM1 line represents a significant advancement in ethical hESC sourcing for regenerative medicine.
Related Concept Videos
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.